Discovery and validation of urinary biomarkers for prostate cancer
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Only 30% of patients with elevated serum prostate specific antigen (PSA) levels who undergo prostate biopsy are diagnosed with prostate cancer (PCa). Novel methods are needed to reduce the number of unnecessary biopsies. We report on the identification and validation of a panel of 12 novel biomarkers for prostate cancer (PCaP), using CE coupled MS. The biomarkers could be defined by comparing first void urine of 51 men with PCa and 35 with negative prostate biopsy. In contrast, midstream urine samples did not allow the identification of discriminatory molecules, suggesting that prostatic fluids may be the source of the defined biomarkers. Consequently, first void urine samples were tested for sufficient amounts of prostatic fluid, using a prostatic fluid indicative panel (“informative” polypeptide panel; IPP). A combination of IPP and PCaP to predict positive prostate biopsy was evaluated in a blinded prospective study. Two hundred thirteen of 264 samples matched the IPP criterion. PCa was detected with 89% sensitivity, 51% specificity. Including age and percent free PSA to the proteomic signatures resulted in 91% sensitivity, 69% specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 2×
“600 (49 of 1459 polypeptides) were statistically analyzed using Benjamini and Hochberg procedures for multiple testing corrections [36].”
MethodHow Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry
Syka, J. E. P., Coon, J. J., Schroeder, M. J., Shabanowitz, J., & Hunt, D. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402700101 · Cited by 2,370 · cited 3×
“Peptides were separated by nRP-HPLC (Agilent 1100; flow split by tee to ~60 nL/min) and introduced into an ETD-capable Finnigan LTQ quadrupole linear IT via nESI.”
MethodSelf-citation
Cited by
Decramer, S., de Peredo, A. G., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J.-L., & Schanstra, J. P. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800001-mcp200 · Cited by 450
Self-citationLiquid biopsy: a step forward towards precision medicine in urologic malignancies
Di Meo, A., Bartlett, J., Cheng, Y., Pasic, M. D., & Yousef, G. M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0644-5 · Cited by 330
Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease
Jantos-Siwy, J., Schiffer, E., Brand, K., Schumann, G., Rossing, K., Delles, C., Mischak, H., & Metzger, J. (2009) · Journal of Proteome Research · doi:10.1021/pr800401m · Cited by 259
Self-citationMischak, H., Coon, J. J., Novak, J., Weissinger, E. M., Schanstra, J. P., & Dominiczak, A. F. (2009) · Mass Spectrometry Reviews · doi:10.1002/mas.20205 · Cited by 193
Self-citationCE‐MS‐based proteomics in biomarker discovery and clinical application
Pontillo, C., Filip, S., Borràs, D. M., Mullen, W., Vlahou, A., & Mischak, H. (2015) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201400115 · Cited by 77
Self-citation
Metadata
- Authors
- Theodorescu, D., Schiffer, E., Bauer, H. W., Douwes, F., Eichhorn, F., Polley, R., Schmidt, T., Schöfer, W., Zürbig, P., Good, D. M., Coon, J. J., & Mischak, H.
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2008-04
- Volume
- 2
- Issue
- 4
- Pages
- 556-570
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2029527636
- Cited by
- 146
- References
- 3
- FWCI
- 11.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discovery and validation of urinary biomarkers for prostate cancer. https://app.cochat.ai/papers/10.1002/prca.200780082
- The paper
- Theodorescu, D., Schiffer, E., Bauer, H. W., Douwes, F., Eichhorn, F., Polley, R., Schmidt, T., Schöfer, W., Zürbig, P., Good, D. M., Coon, J. J., & Mischak, H. (2008). Discovery and validation of urinary biomarkers for prostate cancer. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.200780082
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.